A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells

Nucleic Acids Research

Volumn 43, Issue 19, 2015, Pages 9350-9361

  Castanotto, Daniela ^a   Lin, Min ^a   Kowolik, Claudia ^a   Wang, LiAnn ^b,e   Ren, Xiao Qin ^b,f   Soifer, Harris S ^c   Koch, Troels ^d   Hansen, Bo Rode ^d   Oerum, Henrik ^d   Armstrong, Brian ^a   Wang, Zhigang ^b,g   Bauer, Paul ^b,h   Rossi, John ^a   Stein, C A ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c Biotheranostics   (United States)

^d Roche   (Denmark)

^e Forma Therapeutics   (United States)

^f Synageva BioPharma Corp   (United States)

^g Celgene Avilomics Research   (United States)

^h NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARGONAUTE PROTEIN; MESSENGER RNA; SMALL INTERFERING RNA;

CELL LINE; CHEMISTRY; CYTOPLASM; GENE SILENCING; GENE TRANSFER; GENETIC TRANSFECTION; METABOLISM;

ARGONAUTE PROTEINS; CELL LINE; CYTOPLASM; GENE SILENCING; GENE TRANSFER TECHNIQUES; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84959420851     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv964     Document Type: Article

References (39)

1. Dias,N. and Stein,C.A. (2002) Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther., 1, 347-355.
2. Kole,R., Krainer,A.R. and Altman,S. (2012) RNA therapeutics: beyond RNA interference and antisense oligonucleotides. Nat. Rev. Drug Discov., 11, 125-140.
3. Eckstein,F. (2014) Phosphorothioates, essential components of therapeutic oligonucleotides. Nucleic Acid Ther., 24, 374-387.
4. Obika,S., Morio,K., Nanbu,D. and Imanishi,T. (1997) Synthesis and conformation of 3[prime or minute]-O,4[prime or minute]-C-methyleneribonucleosides, novel bicyclic nucleoside analogues for 2[prime or minute],5[prime or minute]-linked oligonucleotide modification. Chem. Commun., 1643-1644.
5. Singh,S.K., Koshkin,A.A., Wengel,J. and Nielsen,P. (1998) LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition. Chem. Commun., 455-456.
6. Lennox,K.A. and Behlke,M.A. (2011) Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther., 18, 1111-1120.
7. Frieden,M., Christensen,S.M., Mikkelsen,N.D., Rosenbohm,C., Thrue,C.A., Westergaard,M., Hansen,H.F., Orum,H. and Koch,T. (2003) Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA. Nucleic Acids Res., 31, 6365-6372.
8. Kurreck,J., Wyszko,E., Gillen,C. and Erdmann,V.A. (2002) Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res., 30, 1911-1918.
9. Stein,C.A., Hansen,J.B., Lai,J., Wu,S., Voskresenskiy,A., Hog,A., Worm,J., Hedtjarn,M., Souleimanian,N., Miller,P. et al. (2010) Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res., 38,e3.
10. Soifer,H.S., Koch,T., Lai,J., Hansen,B., Hoeg,A., Oerum,H. and Stein,C.A. (2012) Silencing of gene expression by gymnotic delivery of antisense oligonucleotides. Methods Mol. Biol., 815, 333-346.
11. Juliano,R.L. and Carver,K. (2015) Cellular uptake and intracellular trafficking of oligonucleotides. Adv. Drug Deliv. Rev., 87, 35-45.
12. Fisher,T.L., Terhorst,T., Cao,X. and Wagner,R.W. (1993) Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucleic Acids Res., 21, 3857-3865.
13. Bennett,C.F., Chiang,M.Y., Chan,H., Shoemaker,J.E. and Mirabelli,C.K. (1992) Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol., 41, 1023-1033.
14. Pichon,C., Freulon,I., Midoux,P., Mayer,R., Monsigny,M. and Roche,A.C. (1997) Cytosolic and nuclear delivery of oligonucleotides mediated by an amphiphilic anionic peptide. Antisense Nucleic Acid Drug Dev., 7, 335-343.
15. Koller,E., Vincent,T.M., Chappell,A., De,S., Manoharan,M. and Bennett,C.F. (2011) Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res., 39, 4795-4807.
16. Ward,A.J., Norrbom,M., Chun,S., Bennett,C.F. and Rigo,F. (2014) Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides. Nucleic Acids Res., 42, 5871-5879.
17. Vickers,T.A., Freier,S.M., Bui,H.H., Watt,A. and Crooke,S.T. (2014) Targeting of repeated sequences unique to a gene results in significant increases in antisense oligonucleotide potency. PloS One, 9, e110615.
18. ten Asbroek,A.L., van Groenigen,M., Nooij,M. and Baas,F. (2002) The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides. Eur. J. Biochem., 269, 583-592.
19. Liang,X.H., Shen,W., Sun,H., Prakash,T.P. and Crooke,S.T. (2014) TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells. Nucleic Acids Res., 42, 7819-7832.
20. Hefti,M.H., Van Vugt-Van der Toorn,C.J., Dixon,R. and Vervoort,J. (2001) A novel purification method for histidine-tagged proteins containing a thrombin cleavage site. Anal. Biochem., 295, 180-185.
21. Wu,H., Lima,W.F., Zhang,H., Fan,A., Sun,H. and Crooke,S.T. (2004) Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs. J. Biol. Chem., 279, 17181-17189.
22. Akhtar,S. and Juliano,R.L. (1992) Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell Biol., 2, 139-144.
23. McKeon,J. and Khaledi,M.G. (2001) Quantitative nuclear and cytoplasmic localization of antisense oligonucleotides by capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis, 22, 3765-3770.
24. Lorenz,P., Baker,B.F., Bennett,C.F. and Spector,D.L. (1998) Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies. Mol. Biol. Cell, 9, 1007-1023.
25. Zhang,Y., Qu,Z., Kim,S., Shi,V., Liao,B., Kraft,P., Bandaru,R., Wu,Y., Greenberger,L.M. and Horak,I.D. (2011) Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection. Gene Ther., 18, 326-333.
26. Bonifacino,J.S. and Glick,B.S. (2004) The mechanisms of vesicle budding and fusion. Cell, 116, 153-166.
27. Siomi,H. and Siomi,M.C. (2009) RISC hitches onto endosome trafficking. Nat. Cell Biol., 11, 1049-1051.
28. Jakymiw,A., Lian,S., Eystathioy,T., Li,S., Satoh,M., Hamel,J.C., Fritzler,M.J. and Chan,E.K. (2005) Disruption of GW bodies impairs mammalian RNA interference. Nat. Cell Biol., 7, 1267-1274.
29. Schmitter,D., Filkowski,J., Sewer,A., Pillai,R.S., Oakeley,E.J., Zavolan,M., Svoboda,P. and Filipowicz,W. (2006) Effects of Dicer and Argonaute down-regulation on mRNA levels in human HEK293 cells. Nucleic Acids Res., 34, 4801-4815.
30. Sazani,P., Kang,S.H., Maier,M.A., Wei,C., Dillman,J., Summerton,J., Manoharan,M. and Kole,R. (2001) Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. Nucleic Acids Res., 29, 3965-3974.
31. Cazenave,C., Frank,P., Toulme,J.J. and Busen,W. (1994) Characterization and subcellular localization of ribonuclease H activities from Xenopus laevis oocytes. J. Biol. Chem., 269, 25185-25192.
32. Wu,H., Lima,W.F. and Crooke,S.T. (1999) Properties of cloned and expressed human RNase H1. J. Biol. Chem., 274, 28270-28278.
33. Eulalio,A., Behm-Ansmant,I. and Izaurralde,E. (2007) P bodies: at the crossroads of post-transcriptional pathways. Nat. Rev. Mol. Cell Biol., 8, 9-22.
34. Brengues,M., Teixeira,D. and Parker,R. (2005) Movement of eukaryotic mRNAs between polysomes and cytoplasmic processing bodies. Science, 310, 486-489.
35. Bhattacharyya,S.N., Habermacher,R., Martine,U., Closs,E.I. and Filipowicz,W. (2006) Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell, 125, 1111-1124.
36. Jackson,R.J. and Standart,N. (2007) How do microRNAs regulate gene expression? Sci. STKE,re1.
37. Cuellar,J., Martin-Benito,J., Scheres,S.H., Sousa,R., Moro,F., Lopez-Vinas,E., Gomez-Puertas,P., Muga,A., Carrascosa,J.L. and Valpuesta,J.M. (2008) The structure of CCT-Hsc70 NBD suggests a mechanism for Hsp70 delivery of substrates to the chaperonin. Nat. Struct. Mol. Biol., 15, 858-864.
38. Eisenberg,E. and Greene,L.E. (2007) Multiple roles of auxilin and hsc70 in clathrin-mediated endocytosis. Traffic, 8, 640-646.
39. Iwasaki,S., Kobayashi,M., Yoda,M., Sakaguchi,Y., Katsuma,S., Suzuki,T. and Tomari,Y. (2010) Hsc70/Hsp90 chaperone machinery mediates ATP-dependent RISC loading of small RNA duplexes. Mol. Cell, 39, 292-299.